COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas-Reference-Cited by-同舟云学术

COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas

Published:2019-03-13 Issue:6 Volume:474 Page:721-734
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Pierre Charlie,Agopiantz Mikaël,Brunaud Laurent,Battaglia-Hsu Shyue-Fang,Max Antoine,Pouget Celso,Nomine Claire,Lomazzi Sandra,Vignaud Jean-Michel,Weryha Georges,Oussalah Abderrahim,Gauchotte Guillaume^ORCID,Busby-Venner Hélène

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-019-02553-5.pdf

Reference59 articles.

1. Baysal BE (2002) Hereditary paraganglioma targets diverse paraganglia. J Med Genet 39:617–622

2. Parenti G, Zampetti B, Rapizzi E et al (2012) Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. J Oncol 2012:872713. https://doi.org/10.1155/2012/872713

3. Favier J, Amar L, Gimenez-Roqueplo A-P (2015) Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11:101–111. https://doi.org/10.1038/nrendo.2014.188

4. Neumann HPH, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459–1466. https://doi.org/10.1056/NEJMoa020152

5. Welander J, Söderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–R276. https://doi.org/10.1530/ERC-11-0170

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of metastatic pheochromocytomas and paragangliomas: when and what;Current Problems in Cancer;2024-08

2. Pathology of Adrenocortical Carcinoma and Malignant Pheochromocytoma;Updates in Surgery;2024-07-25

3. Genetic and Molecular Biomarkers in Aggressive Pheochromocytomas and Paragangliomas;International Journal of Molecular Sciences;2024-06-28

4. Analysis of clinical and pathological characteristics of retroperitoneal paraganglioma and associated prognostic factors;Journal of Surgical Oncology;2024-06-12

5. Identification of Predictors of Metastatic Potential in Paragangliomas to Develop a Prognostic Score (PSPGL);Journal of the Endocrine Society;2024-05-07